Showing results (351-360 of 2,509) with videos related to

Sort By:
Pageof 251
Clinical Lymphoma, Myeloma & Leukemia|May 25, 2022
Impact of Hypomethylating Agent Use on Hospital and Emergency Room Visits, and Predictors of Early Discontinuation in Patients With Higher-Risk Myelodysplastic SyndromesAmer M Zeidan, Namita Joshi, Hrishikesh Kale, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 27, 2022
Results of a Prospective Non-Interventional Post-Authorization Safety Study of Idelalisib in GermanyManuela A Hoechstetter, Wolfgang Knauf, Silvia Dambacher, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 24, 2021
Efficacy and Safety of Homoharringtonine for the Treatment of Acute Myeloid Leukemia: A Meta-analysisRuihua Mi, Jin Zhao, Lin Chen, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 20, 2022
Outcomes of Tisagenlecleucel in Lymphoma Patients With Predominant Management in an Ambulatory SettingSunita D Nasta, Mitchell E Hughes, Esin C Namoglu, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 2, 2021
Comparison of Upfront Transplantation and Pretransplant Cytoreductive Therapy for Advanced Myelodysplastic SyndromeHong Wang, Yan Li, Qingyu Xu, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 10, 2021
Direct Medical Costs Associated With Treatment Nonpersistence in Patients With Higher-Risk Myelodysplastic Syndromes Receiving Hypomethylating Agents: A Large Retrospective Cohort AnalysisNamita Joshi, Hrishikesh Kale, Shelby Corman, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 28, 2021
Acute Myeloid Leukemia: Historical Perspective and Progress in Research and Therapy Over 5 DecadesHagop M Kantarjian, Nicholas J Short, Amir T Fathi, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 30, 2021
Efficacy and Safety of Imatinib Treatment in Elderly Patients With Chronic Myeloid Leukemia: Real-Life Data and a Single-Center ExperienceAhmet Emre Eşkazan, Deniz Özmen, Mert Öztaş, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 1, 2021
A Real-life Turkish Experience of Venetoclax Treatment in High-risk Myelodysplastic Syndrome and Acute Myeloid LeukemiaAliihsan Gemici, Fahir Ozkalemkas, Mehmet Hilmi Dogu, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 7, 2020
Consensus Guidelines on the Diagnosis of Multiple Myeloma and Related Disorders: Recommendations of the Myeloma Canada Research Network Consensus Guideline ConsortiumDebra J Bergstrom, Rami Kotb, Martha L Louzada, et al.
Pageof 251